156 related articles for article (PubMed ID: 2223394)
1. Monoclonal antibody therapy of cancer.
DiMaggio JJ; Scheinberg DA; Houghton AN
Cancer Chemother Biol Response Modif; 1990; 11():177-203. PubMed ID: 2223394
[No Abstract] [Full Text] [Related]
2. Monoclonal antibody therapy of cancer.
Jurcic JG; Scheinberg DA; Houghton AN
Cancer Chemother Biol Response Modif; 1993; 14():129-49. PubMed ID: 8312102
[No Abstract] [Full Text] [Related]
3. Immunological approaches to tumor therapy. Monoclonal antibodies, tumor vaccines, and anti-idiotypes.
Hellström KE; Hellström I
Targeted Diagn Ther; 1989; 2():1-39. PubMed ID: 2519542
[No Abstract] [Full Text] [Related]
4. [Active specific immunotherapy of cancer using anti-idiotypic monoclonal antibodies].
Castello G; D'Alessio V
Clin Ter; 1991 May; 137(3):155-67. PubMed ID: 1831084
[TBL] [Abstract][Full Text] [Related]
5. Anti-idiotypic tumor vaccines.
Hellström KE; Hellström I
Int Rev Immunol; 1989; 4(4):337-46. PubMed ID: 2519931
[No Abstract] [Full Text] [Related]
6. Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody.
Robins RA; Denton GW; Hardcastle JD; Austin EB; Baldwin RW; Durrant LG
Cancer Res; 1991 Oct; 51(19):5425-9. PubMed ID: 1913661
[TBL] [Abstract][Full Text] [Related]
7. The anti-idiotype vaccines for immunotherapy.
Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
[TBL] [Abstract][Full Text] [Related]
8. Tumor associated antigen (TAA) mimicry and immunotherapy of malignant diseases from anti-idiotypic antibodies to peptide mimics.
Wang X; Luo W; Foon KA; Ferrone S
Cancer Chemother Biol Response Modif; 2001; 19():309-26. PubMed ID: 11686020
[No Abstract] [Full Text] [Related]
9. Human tumor-associated antigen mimicry by anti-idiotypic antibodies. Immunogenicity and clinical trials in patients with solid tumors.
Ferrone S
Ann N Y Acad Sci; 1993 Aug; 690():214-24. PubMed ID: 8368740
[No Abstract] [Full Text] [Related]
10. Modern immunotherapy of cancer.
Ravikumar TS; Steele GD
Adv Surg; 1991; 24():41-68. PubMed ID: 1996529
[No Abstract] [Full Text] [Related]
11. Novel anti-CD20 antibody TGLA with enhanced antibody-dependent cell-mediated cytotoxicity mediates potent anti-lymphoma activity.
Lv M; Lin Z; Qiao C; Gen S; Lang X; Li Y; Feng J; Shen B
Cancer Lett; 2010 Aug; 294(1):66-73. PubMed ID: 20202740
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody-based therapy of neuroblastoma.
Cheung NK; Kushner BH; Kramer K
Hematol Oncol Clin North Am; 2001 Oct; 15(5):853-66. PubMed ID: 11765377
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies for cancer immunotherapy.
Weiner LM; Dhodapkar MV; Ferrone S
Lancet; 2009 Mar; 373(9668):1033-40. PubMed ID: 19304016
[TBL] [Abstract][Full Text] [Related]
14. Human anti-murine immunoglobulin responses and immune functions in cancer patients receiving murine monoclonal antibody therapy.
Blottière HM; Steplewski Z; Herlyn D; Douillard JY
Hum Antibodies Hybridomas; 1991 Jan; 2(1):16-25. PubMed ID: 1908336
[TBL] [Abstract][Full Text] [Related]
15. Technology evaluation: Onyvax-105, Onyvax.
Blumenthal RD
Curr Opin Mol Ther; 2003 Dec; 5(6):668-72. PubMed ID: 14755894
[TBL] [Abstract][Full Text] [Related]
16. Serotherapy of cancer.
Harris DT; Mastrangelo MJ
Semin Oncol; 1989 Jun; 16(3):180-98. PubMed ID: 2658082
[No Abstract] [Full Text] [Related]
17. Monoclonal antibody therapy of cancer.
Jurcic JG; Scheinberg DA; Houghton AN
Cancer Chemother Biol Response Modif; 1997; 17():195-216. PubMed ID: 9551215
[No Abstract] [Full Text] [Related]
18. [Cancer therapy by using bispecific antibody].
Azuma A; Niitani H; Okumura K
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1535-42. PubMed ID: 1872618
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody therapy of cancer.
Jurcic JG; Scheinberg DA; Houghton AN
Cancer Chemother Biol Response Modif; 1994; 15():152-75. PubMed ID: 7779584
[No Abstract] [Full Text] [Related]
20. Anti-idiotypic antibody abagovomab in advanced ovarian cancer.
Bauerschlag DO; Schem C; Baumann K; Harter P; Hilpert F; Wagner U; du Bois A; Pfisterer J
Future Oncol; 2008 Dec; 4(6):769-73. PubMed ID: 19086842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
